TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8867548

Group type: EXPERIMENTAL
Intervention: Discontinued low dose methotrexate (MTX) prior to and during surgery (Group 1, n = 19)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Continued low dose methotrexate (MTX) throughout the perioperative period (Group 2, n = 13)
Number of subjects: 32
Study: 2258342

Group type: EXPERIMENTAL
Intervention: Single dose of pefloxacin 800 mg
Number of subjects: 222

Group type: COMPARATOR
Intervention: Five-day treatment with norfloxacin 400 mg twice daily
Number of subjects: 222
Study: 6987112

Group type: EXPERIMENTAL
Intervention: Rifamycin SV by intramuscular injection and topically
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Rifamycin SV by injection only
Number of subjects: 144

Group type: COMPARATOR
Intervention: Routine treatment used at the particular centre
Number of subjects: 144
Study: 31578784

Group type: EXPERIMENTAL
Intervention: CIC cessation
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: CIC cessation in paraplegic participants
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Years since SCI
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: ≥4 urinary tract infections (UTIs) in a year
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Tetraplegia
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: CIC cessation in tetraplegics
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Recurrent UTIs
Number of subjects: 176
Study: 30024217

Group type: EXPERIMENTAL
Intervention: Posttraumatic Growth Inventory (PTGI)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Stress Related Growth Scale-Revised (SRGS-R)
Number of subjects: 613
Study: 26656728

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right dlPFC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cathodal tDCS over the right dlPFC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 25316715

Group type: EXPERIMENTAL
Intervention: t:slim Insulin Pump
Number of subjects: 72

Group type: COMPARATOR
Intervention: Revel Insulin Pump
Number of subjects: 72
Study: 23171880

Group type: EXPERIMENTAL
Intervention: Plasma sICAM-1 level (quartile 4 vs. quartile 1)
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Plasma hs-CRP level (quartile 4 vs. quartile 1)
Number of subjects: 1536
Study: 21607987

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Dyslipidemia
Number of subjects: 427
Study: 19489765

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (1.6 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 16957638

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 300 mg daily for 3 days, tapered over 1 week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous metoclopramide 10 mg 3 times daily for 1 week
Number of subjects: 40
Study: 15327918

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC; -110 degrees C) for 2 min, repeated three times per week for 3 months (13 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Winter swimming (WS) in ice-cold water for 20 s, repeated three times per week for 3 months (13 weeks)
Number of subjects: 20
Study: 10753831

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF (2.5 or 5 microg/kg/day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 9525336

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (850 mg/day)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: VDR gene polymorphisms
Number of subjects: 369
Study: 8205268

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (50 mg/day)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/day)
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 29133
Study: 3330661

Group type: EXPERIMENTAL
Intervention: Intervention group (physician antismoking advice)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (customary care practices)
Number of subjects: 258
Study: 28929400

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 276
Study: 26310941

Group type: EXPERIMENTAL
Intervention: Baduanjin Qigong (BQG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (daily walking for 30 min)
Number of subjects: 100
Study: 24256336

Group type: EXPERIMENTAL
Intervention: multi‐component intervention for smoking cessation and cardiovascular disease risk reduction
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: smokers with psychosis
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: smokers diagnosed with psychosis
Number of subjects: 200
Study: 24250874

Group type: EXPERIMENTAL
Intervention: Carbamazepine (300-600 mg/day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (450-900 mg/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 21353105

Group type: EXPERIMENTAL
Intervention: IV acetaminophen 1000 mg q6h
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: IV acetaminophen 650 mg q4h
Number of subjects: 244

Group type: COMPARATOR
Intervention: IV placebo 100 mL q6h
Number of subjects: 244

Group type: COMPARATOR
Intervention: IV placebo 65 mL q4h
Number of subjects: 244
Study: 19128627

Group type: EXPERIMENTAL
Intervention: Parental guide and treatment algorithm
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care with acetaminophen (15 mg/kg) and morphine (0.3 mg/kg)
Number of subjects: 80
Study: 16179595

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Perindopril (8 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nitroprusside
Number of subjects: 10
Study: 14509502

Group type: EXPERIMENTAL
Intervention: Selective hepatic vascular exclusion (SHVE)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Pringle maneuver
Number of subjects: 110
Study: 11219597

Group type: EXPERIMENTAL
Intervention: Centroid method with floating reference
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cross-sectional fractional area change (FAC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Segmental FAC by fixed reference
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Segmental FACs
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Centroid method with floating reference and cross-sectional FACs
Number of subjects: 80
Study: 8851908

Group type: EXPERIMENTAL
Intervention: Convective cooling of the hand (60 min) at air temperatures of 0, 4, 10, and 16 degrees C
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Contact cooling of the finger pad (5 min) with an aluminum cube at temperatures of -7, 0, and 7 degrees C
Number of subjects: 28
Study: 1543449

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg/d)
Number of subjects: 3711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3711
Study: 2860182

Group type: EXPERIMENTAL
Intervention: Postoperative rinsing with povidone-iodine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Open abdominal wall with pancreatic space packed
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conservative closure of the abdominal wall
Number of subjects: 17
Study: 30403954

Group type: EXPERIMENTAL
Intervention: Zoliflodacin 2 g
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Zoliflodacin 3 g
Number of subjects: 179

Group type: COMPARATOR
Intervention: Ceftriaxone 500 mg
Number of subjects: 179
Study: 29231521

Group type: EXPERIMENTAL
Intervention: Acupotomy, applied once every two weeks for a total of 3 times
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture, applied once every day for 6 weeks
Number of subjects: 60
Study: 24533515

Group type: EXPERIMENTAL
Intervention: Webinar AFIX consultation
Number of subjects: 61

Group type: COMPARATOR
Intervention: In-person AFIX consultation
Number of subjects: 61
Study: 22958105

Group type: EXPERIMENTAL
Intervention: New warning label
Number of subjects: 0

Group type: COMPARATOR
Intervention: Old warning label
Number of subjects: 0
Study: 20670400

Group type: EXPERIMENTAL
Intervention: C282Y-carrier status
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: H63D-carrier status
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: S65C-carrier status
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: HFE homozygous or compound heterozygous carriers
Number of subjects: 667
Study: 17896116

Group type: EXPERIMENTAL
Intervention: Total-etching with 36% phosphoric acid followed by an acetone-based adhesive (Prime&Bond NT)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive system (Xeno III)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Acetone-based adhesive (Prime&Bond NT) without prior acid conditioning
Number of subjects: 240

Group type: COMPARATOR
Intervention: Calcium hydroxide cement (Dycal)
Number of subjects: 240
Study: 15747239

Group type: EXPERIMENTAL
Intervention: Age 17-65 years
Number of subjects: 144485

Group type: EXPERIMENTAL
Intervention: Age >= 65 years
Number of subjects: 144485

Group type: COMPARATOR
Intervention: Derivation cohort
Number of subjects: 144485

Group type: COMPARATOR
Intervention: Validation cohort
Number of subjects: 144485
Study: 12554608

Group type: EXPERIMENTAL
Intervention: Cyanamide (200 mg daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cyanamide
Number of subjects: 26
Study: 11029348

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8800992

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine (500 micrograms delivered over 72 h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 16
Study: 1738571

Group type: EXPERIMENTAL
Intervention: Maprotiline (MT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Both agents (AT and MT)
Number of subjects: 35
Study: 6227456

Group type: EXPERIMENTAL
Intervention: Insertion of the laparoscopic Trocar without the use of carbon dioxide gas
Number of subjects: 914
Study: 30832590

Group type: EXPERIMENTAL
Intervention: CVS as a video stylet (CVS‐V)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: CVS as a lightwand (CVS‐L)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Direct laryngoscope (DL)
Number of subjects: 150
Study: 30086747

Group type: EXPERIMENTAL
Intervention: Fixed-period six month recall
Number of subjects: 2372

Group type: EXPERIMENTAL
Intervention: Risk-based recall
Number of subjects: 2372

Group type: EXPERIMENTAL
Intervention: Fixed-period twenty-four month recall
Number of subjects: 2372
Study: 26354593

Group type: EXPERIMENTAL
Intervention: Music-with-movement intervention, developed by a registered music therapist, taught to staff over five weekly 1.5 h sessions.
Number of subjects: 0
Study: 24771728

Group type: COMPARATOR
Intervention: Steel wire closure
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Polyester suture closure
Number of subjects: 200
Study: 22395920

Group type: EXPERIMENTAL
Intervention: Bovine intestinal alkaline phosphatase (bIAP) administered as an intravenous bolus followed by continuous infusion for 36 hours.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo administered as an intravenous bolus followed by continuous infusion for 36 hours.
Number of subjects: 63
Study: 20617218

Group type: EXPERIMENTAL
Intervention: Ball-socket attachment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Bar-clip attachment
Number of subjects: 18
Study: 18520981

Group type: EXPERIMENTAL
Intervention: Creatine (10 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine and Minocycline
Number of subjects: 0
Study: 15942183

Group type: EXPERIMENTAL
Intervention: Sequential antiarrhythmic therapy (propafenone, sotalol, disopyramide) followed by amiodarone if needed
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Amiodarone as the third antiarrhythmic agent
Number of subjects: 128
Study: 12374449

Group type: EXPERIMENTAL
Intervention: Higher ability (HA) group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lower ability (LA) group
Number of subjects: 60
Study: 9931196

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4 g/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1.2 g/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7791815

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (7.5 mg daily for two years)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 2505689

Group type: EXPERIMENTAL
Intervention: Inspiratory time limited to 0.5 seconds (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ventilator rate reduced with inspiratory time reaching 1.0 seconds (Group B)
Number of subjects: 40
Study: 30951609

Group type: EXPERIMENTAL
Intervention: Supportive Counseling
Number of subjects: 46

Group type: COMPARATOR
Intervention: Behavioral Activation
Number of subjects: 46
Study: 28557178

Group type: EXPERIMENTAL
Intervention: Antidepressants (imipramine, venlafaxine, escitalopram)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Anticonvulsants (pregabalin, oxcarbazepine)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Anticonvulsants
Number of subjects: 244
Study: 26262777

Group type: EXPERIMENTAL
Intervention: dolutegravir + abacavir/lamivudine
Number of subjects: 833

Group type: COMPARATOR
Intervention: efavirenz/tenofovir/emtricitabine
Number of subjects: 833
Study: 23602612

Group type: EXPERIMENTAL
Intervention: Latent variable approach for modeling longitudinal and dropout data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional analyses using time-to-event approach
Number of subjects: 0
Study: 22083060

Group type: EXPERIMENTAL
Intervention: Alcohol-free antimicrobial mouth rinse containing cetylpyridinium chloride
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (no mouth rinse)
Number of subjects: 226
Study: 18942013

Group type: EXPERIMENTAL
Intervention: Writing about a happy event once a week and noting happy events each day for four weeks, receiving small presents after writing.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Writing about and noting trivial neutral events, no small presents.
Number of subjects: 58
Study: 16382116

Group type: EXPERIMENTAL
Intervention: Psychoeducational interventions for facilitating transition to survivorship
Number of subjects: 558
Study: 14576100

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g three times a day)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Imipenem-cilastatin (500 mg four times a day)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 281

Group type: COMPARATOR
Intervention: Imipenem-cilastatin
Number of subjects: 281
Study: 11113068

Group type: EXPERIMENTAL
Intervention: 5 microg/kg rhuIL-10
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 8956393

Group type: EXPERIMENTAL
Intervention: EMLA cream for a minimum of 30 minutes
Number of subjects: 41

Group type: COMPARATOR
Intervention: Lidocaine infiltration with 3 mL of 1% lidocaine
Number of subjects: 41
Study: 1555269

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Conservative strategy
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Not current smoker
Number of subjects: 3339
Study: 4015742

Group type: EXPERIMENTAL
Intervention: suprofen (200 mg/ml) as i.v. bolus injections
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: suprofen (200 mg/ml) as infusions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: suprofen (200 mg/ml) as i.v. bolus injections and infusions
Number of subjects: 12
Study: 29381588

Group type: EXPERIMENTAL
Intervention: Simulation group (4 sessions of 15 minutes each, 3 self-directed, 1 with feedback)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Simulation group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 27683839

Group type: EXPERIMENTAL
Intervention: Telephone-based weight management and healthy lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 24447085

Group type: EXPERIMENTAL
Intervention: rs7041_C allele (haplotype GC1s)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: GC1f haplotype
Number of subjects: 198
Study: 22651863

Group type: EXPERIMENTAL
Intervention: Nonresynchronization implantable cardioverter-defibrillator (ICD)
Number of subjects: 1191
Study: 20134408

Group type: EXPERIMENTAL
Intervention: Olanzapine (OLZ) 5 mg for 3 days then OLZ 10 mg for 12 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 30
Study: 18800994

Group type: EXPERIMENTAL
Intervention: Repeat trial for high responders (HR)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Repeat trial for low responders (LR)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall plaque accumulation and bleeding index
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gingival index
Number of subjects: 37
Study: 16410889

Group type: EXPERIMENTAL
Intervention: HBV vaccination
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Not applicable (control group: blood donor candidates)
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Not applicable (control group: unvaccinated HCW)
Number of subjects: 1433

Group type: EXPERIMENTAL
Intervention: Full set of HBV vaccines
Number of subjects: 1433
Study: 12120775

Group type: EXPERIMENTAL
Intervention: Flowable resin composite (FRC) with thickness of 0.5 mm, 1 mm, or 2 mm as a gingival increment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group using hybrid resin composite for both gingival and occlusal increments
Number of subjects: 60
Study: 11185684

Group type: EXPERIMENTAL
Intervention: Iodixanol-270 (20 ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iopentol-150 (20 ml)
Number of subjects: 0
Study: 7733025

Group type: EXPERIMENTAL
Intervention: Beta formula (26% palmitic acid, esterified predominantly to the sn‐2 position)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Alpha formula (palmitate mainly at the sn‐1,3 positions)
Number of subjects: 12
Study: 2291870

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6990473

Group type: EXPERIMENTAL
Intervention: Cephazolin‐cephalexin (37 patients)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Methenamine hippurate (42 patients)
Number of subjects: 79
Study: 30372375

Group type: EXPERIMENTAL
Intervention: Bisexual victim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Straight victim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lesbian victim
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 0
Study: 30691508

Group type: EXPERIMENTAL
Intervention: Planned early delivery (initiation of delivery within 48 h of randomisation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (expectant management)
Number of subjects: 0
Study: 28596452

Group type: EXPERIMENTAL
Intervention: Nurse-led multidomain intensive vascular care
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 126
Study: 25863003

Group type: EXPERIMENTAL
Intervention: High-activation positive mood induction
Number of subjects: 106

Group type: COMPARATOR
Intervention: Low-activation positive mood induction
Number of subjects: 106

Group type: COMPARATOR
Intervention: Neutral mood condition
Number of subjects: 106
Study: 23480315

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Bupropion-SR
Number of subjects: 821
Study: 21425736

Group type: EXPERIMENTAL
Intervention: FAST Model
Number of subjects: 135

Group type: COMPARATOR
Intervention: Matrix Model
Number of subjects: 135
Study: 19590019

Group type: EXPERIMENTAL
Intervention: Active corticosteroid inhaler (quadrupling the dose)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo inhaler (no change in corticosteroid dose)
Number of subjects: 403
Study: 15841498

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with cruciferous vegetables (broccoli)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Basal diet devoid of fruits and vegetables
Number of subjects: 38
Study: 11870117

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg orally three times a day for 4-6 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 34
Study: 10411763

Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg‐1 midazolam (n=100)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 1.0 mg.kg‐1 midazolam (n=100)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intranasal ethyl chloride spray
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.5 mg.kg‐1 midazolam
Number of subjects: 200

Group type: COMPARATOR
Intervention: 1.0 mg.kg‐1 midazolam
Number of subjects: 200
Study: 7671027

Group type: EXPERIMENTAL
Intervention: Maximal isometric pressures at the tongue blade site for younger subjects
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Peak swallowing pressures
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Difference scores of maximum isometric to swallowing pressures at the tongue blade
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cerebral atrophy incidence
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Incidence of periventricular white matter lesions
Number of subjects: 25